Bexal Farmacêutica

Bexal Farmacéutica is a prominent Spanish pharmaceutical company specializing in the development and commercialization of generic medicines. Founded in 1998 and currently operating as a subsidiary of Sandoz, the company provides a broad portfolio of high-quality, affordable therapeutic options across various medical fields. Its product range includes treatments for cardiovascular diseases, central nervous system disorders, gastrointestinal conditions, and oncology. Bexal plays a critical role in the Spanish healthcare landscape by enhancing the sustainability of the public health system through cost-effective drug alternatives. The company adheres to rigorous international quality standards, leveraging the global manufacturing network of its parent organization. Bexal remains one of the most recognized and trusted generic brands among healthcare professionals and patients in Spain.